Type 2 Diabetes Trial, Not Yet Recruiting NCT07374744 Sponsor: Abant Izzet Baysal University Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Not Yet Recruiting

NCT07374744
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged between 18 and 65 years.
  • People who can read, write, understand, and speak Turkish.
  • People who have been diagnosed with type 2 diabetes for at least one year.
  • People who are currently taking diabetes tablets and/or insulin for their diabetes.
  • People who have had a blood sugar control measurement (called HbA1c) above 7% at least once in the past 3 months.
  • People who are willing to take part in the study on a voluntary basis.
  • People who own a personal device, such as a smartphone, that can play interactive videos.
  • People who are able to use a smartphone to play interactive videos, which will be checked by the trial site before enrolment.
  • People who own a smartphone with an active internet connection.
  • People who are able to attend all required follow-up appointments during the study.
  • People with a body mass index (a measure of body weight relative to height) of 18.5 or above.
  • People who do not follow a vegan or vegetarian diet.
  • People whose haemoglobin (a measure of red blood cells) falls within the normal range — for women, between 12 and 16 g/dL; for men, between 14 and 18 g/dL.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have previously received diabetes education delivered through video.
  • People who currently use or have previously used a video-based tool or program to help manage type 2 diabetes.
  • People who have severe vision, hearing, cognitive, or physical difficulties that may make participation difficult.
  • People who are admitted to hospital as an inpatient during the study period.
  • People who are pregnant, planning to become pregnant within the next 6 months, or who become pregnant during the study.
  • People who are breastfeeding during the study period.
  • People who are currently taking any medication for weight loss.
  • People who have been diagnosed with sickle cell anaemia, or who receive such a diagnosis during the study period.
  • People who are receiving haemodialysis (a kidney treatment), have recently had significant bleeding or a blood transfusion, or are receiving a hormone called erythropoietin to stimulate red blood cell production.
  • People who have a diagnosed mental health condition such as major depression, bipolar disorder, or schizophrenia.
  • People who are taking part in another diabetes-related program or intervention at the same time as this study.
  • People who use an insulin pump to manage their diabetes.
  • People who manage their diabetes through diet alone, without any medication.
  • People who are following a diet prescribed and supervised by a dietitian because of another medical condition or a surgical procedure.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +903742534520

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Abant Izzet Baysal University
Registry
ClinicalTrials.gov
Start date
1 August 2026
Est. completion
30 November 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

The Comprehensive Diabetes Self-Management Scale (CDSMS); Hba1c; Diabetes Empowerment Scale (DES); Estimated average glucose (ADAG); Fasting plasma glucose (FPG)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov